Products

Our main brands

 
 
 
 

Active substance

 

Trazodone

Therapeutic areas

 

Mental Health


 

Active substance

 

Lurasidone

Therapeutic areas

 

Mental Health

Trademark licensed by Sumitomo Dainippon Pharma Co. Ltd


 

Active substance

 

Nimesulide

Therapeutic areas

 

Pain & inflammation Disorders

Trademark licensed by Helsinn Healthcare S.A.


 
 

Active substance

 

Fentanil

Therapeutic areas

 

Pain & inflammation Disorders


 

Active substance

 

Paracetamol

Therapeutic areas

 

Pain, Antipyresis


 

Active substance

 

Ibuprofen

Therapeutic areas

 

Analgesia, Inflammation


 

Active substance

 

Dalbavancin

Therapeutic areas

 

Infection Control and Infectious Diseases

Trademark licensed by Allergan Inc


 
 

Active substance

 

Prulifloxacin

Therapeutic areas

 

Infection Control and Infectious Diseases


 

Active substance

 

Benzydamine Hydrochloride

Therapeutic areas

 

Oral Care and Sore Throat


 
 
 

Active substance

 

Benzydamine Hydrochloride

Therapeutic areas

 

Gynecology


 

Active substance

 

Hyaluronic/Ascorbic acid

Therapeutic areas

 

Gynecology


 

Active substance

 

Erdosteine

Therapeutic areas

 

Diseases of the respiratory tract


 

Therapeutic areas

 

Brain Supplements


 

Therapeutic areas

 

Brain Supplements


 
 

Active substance

 

Sodium hypochlorite

Therapeutic areas

 

Disinfection


Pharmacovigilance


If you experienced adverse reactions after taking an Angelini product, contact your doctor or call on the nearest health facility as soon as possible.

If you need to contact Angelini Pharma Pharmacovigilance you may refer to individual countries websites listed under section "Angelini Wordlwide".

Angelini S.p.a.
Viale Amelia 70, 00181 Roma
P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585
Ufficio del registro delle imprese: Roma
Capitale: € 18.594.000,00 I.V.

© Angelini S.p.a. - Tutti i diritti riservati